Advertisement
Screener

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Other

Corbus Pharmaceuticals Holdings, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2022-11-08: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market.
  • 2022-08-09: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market.
  • 2022-05-10: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market.
  • 2021-11-12: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market.
FiledFormItemAs filed
2022-11-0810-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market
2022-08-0910-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market
2022-05-1010-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market
2021-11-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · Nasdaq Global Market
2021-08-1210-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · NASDAQ
2021-05-1310-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · NASDAQ
2021-03-1510-KStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · NASDAQ
2020-11-0910-QStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · NASDAQ
2020-08-3110-Q/AStock registered under Section 12(b)Common Stock, par value $0.0001 per share · CRBP · NASDAQ
2019-11-0710-QEmerging growth companyYes
2019-08-0810-QEmerging growth companyYes
2019-05-0910-QEmerging growth companyYes
2019-03-1210-KEmerging growth companyYes
2018-11-0810-QEmerging growth companyYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
Annexon, Inc. (ANNX)United States$0.147B-4.22
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
Atrium Therapeutics, Inc. (RNA)United States$0.140B
Curanex Pharmaceuticals Inc (CURX)United States$0.138B
TuHURA Biosciences, Inc./NV (HURA)United States$0.134B-4.88
Unicycive Therapeutics, Inc. (UNCY)United States$0.134B-3.70
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31
MEDICINOVA INC (MNOV)United States$0.130B-6.04
IMMUNIC, INC. (IMUX)United States$0.127B-1.88